Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen

Background: Ethanolamine plasmalogen (PlsEtn) is a subclass of ethanolamine glycerophospholipids (EtnGpls) and is abundantly found in some marine invertebrates, including ascidian <i>Halocynthia roretzi</i>. PlsEtn is reported to exhibit physiological and nutritional hepatic functions; h...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryosuke Sogame, Yuki Tominaga, Momoka Echigoya, Kiyotaka Nakagawa, Michihiro Fukushima, Teruo Miyazawa, Mikio Kinoshita, Shinji Yamashita
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/15/11/5968
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850130869281357824
author Ryosuke Sogame
Yuki Tominaga
Momoka Echigoya
Kiyotaka Nakagawa
Michihiro Fukushima
Teruo Miyazawa
Mikio Kinoshita
Shinji Yamashita
author_facet Ryosuke Sogame
Yuki Tominaga
Momoka Echigoya
Kiyotaka Nakagawa
Michihiro Fukushima
Teruo Miyazawa
Mikio Kinoshita
Shinji Yamashita
author_sort Ryosuke Sogame
collection DOAJ
description Background: Ethanolamine plasmalogen (PlsEtn) is a subclass of ethanolamine glycerophospholipids (EtnGpls) and is abundantly found in some marine invertebrates, including ascidian <i>Halocynthia roretzi</i>. PlsEtn is reported to exhibit physiological and nutritional hepatic functions; however, the effects of dietary PlsEtn on continuous acetaminophen (APAP)-induced hepatic injury, including oxidative stress and impaired lipid metabolism, remain unclear. Herein, we investigated the dietary effects of PlsEtn from ascidian on chronic hepatic injury in APAP-treated mice. Methods: Five-week-old male ICR mice were divided into four groups (<i>n</i> = 12), which were treated with the respective experimental diet for two weeks and then the respective APAP-containing diet for five weeks. The results obtained after administering the PlsEtn-rich diet were compared with those obtained after the administration of a phosphatidylethanolamine (PtdEtn)-rich diet, a major subclass of hepatic EtnGpls. Results: The PlsEtn-rich diet effectively suppressed the APAP-induced decrease in body and liver weights of mice; however, this suppressive effect was not observed in mice fed a PtdEtn-rich diet. APAP administration decreased the total fatty acid content in the liver, whereas a PlsEtn-rich diet alleviated this decrease and increased the hepatic content of docosahexaenoic acid (DHA), which exhibits various hepatic functions. Moreover, dietary EtnGpl rich in PlsEtn or PtdEtn suppressed APAP-induced lipid oxidation in the liver. The protein expression results revealed that dietary EtnGpls reduced the expression of certain apoptosis-related proteins in the livers of APAP-administered mice compared to that in the APAP group. This reduction was particularly more effective in mice fed the PlsEtn-rich diet than in those on the PtdEtn-rich diet. Conclusions: Dietary EtnGpls, particularly PlsEtn, alleviated the hepatic cellular stress caused by continuous APAP consumption. These beneficial effects may depend on the subclass and may be related to DHA metabolism in the liver. The results of this study contribute to the understanding of the role of PlsEtn in maintaining liver health.
format Article
id doaj-art-02b07894920f4e438fdfd6186a9a5a68
institution OA Journals
issn 2076-3417
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj-art-02b07894920f4e438fdfd6186a9a5a682025-08-20T02:32:34ZengMDPI AGApplied Sciences2076-34172025-05-011511596810.3390/app15115968Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous AcetaminophenRyosuke Sogame0Yuki Tominaga1Momoka Echigoya2Kiyotaka Nakagawa3Michihiro Fukushima4Teruo Miyazawa5Mikio Kinoshita6Shinji Yamashita7Department of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanDepartment of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanDepartment of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanFood Function Analysis Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai 980-8572, JapanDepartment of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanFood and Biotechnology Platform Promoting Project, New Industry Creation Hatchery Center (NICHe), Tohoku University, Sendai 980-8579, JapanDepartment of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanDepartment of Life and Food Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, JapanBackground: Ethanolamine plasmalogen (PlsEtn) is a subclass of ethanolamine glycerophospholipids (EtnGpls) and is abundantly found in some marine invertebrates, including ascidian <i>Halocynthia roretzi</i>. PlsEtn is reported to exhibit physiological and nutritional hepatic functions; however, the effects of dietary PlsEtn on continuous acetaminophen (APAP)-induced hepatic injury, including oxidative stress and impaired lipid metabolism, remain unclear. Herein, we investigated the dietary effects of PlsEtn from ascidian on chronic hepatic injury in APAP-treated mice. Methods: Five-week-old male ICR mice were divided into four groups (<i>n</i> = 12), which were treated with the respective experimental diet for two weeks and then the respective APAP-containing diet for five weeks. The results obtained after administering the PlsEtn-rich diet were compared with those obtained after the administration of a phosphatidylethanolamine (PtdEtn)-rich diet, a major subclass of hepatic EtnGpls. Results: The PlsEtn-rich diet effectively suppressed the APAP-induced decrease in body and liver weights of mice; however, this suppressive effect was not observed in mice fed a PtdEtn-rich diet. APAP administration decreased the total fatty acid content in the liver, whereas a PlsEtn-rich diet alleviated this decrease and increased the hepatic content of docosahexaenoic acid (DHA), which exhibits various hepatic functions. Moreover, dietary EtnGpl rich in PlsEtn or PtdEtn suppressed APAP-induced lipid oxidation in the liver. The protein expression results revealed that dietary EtnGpls reduced the expression of certain apoptosis-related proteins in the livers of APAP-administered mice compared to that in the APAP group. This reduction was particularly more effective in mice fed the PlsEtn-rich diet than in those on the PtdEtn-rich diet. Conclusions: Dietary EtnGpls, particularly PlsEtn, alleviated the hepatic cellular stress caused by continuous APAP consumption. These beneficial effects may depend on the subclass and may be related to DHA metabolism in the liver. The results of this study contribute to the understanding of the role of PlsEtn in maintaining liver health.https://www.mdpi.com/2076-3417/15/11/5968acetaminophenascidiandocosahexaenoic acidliver diseasephosphatidylethanolamineplasmalogen
spellingShingle Ryosuke Sogame
Yuki Tominaga
Momoka Echigoya
Kiyotaka Nakagawa
Michihiro Fukushima
Teruo Miyazawa
Mikio Kinoshita
Shinji Yamashita
Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
Applied Sciences
acetaminophen
ascidian
docosahexaenoic acid
liver disease
phosphatidylethanolamine
plasmalogen
title Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
title_full Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
title_fullStr Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
title_full_unstemmed Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
title_short Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
title_sort dietary ethanolamine plasmalogen from ascidian alleviates chronic hepatic injury in mice treated with continuous acetaminophen
topic acetaminophen
ascidian
docosahexaenoic acid
liver disease
phosphatidylethanolamine
plasmalogen
url https://www.mdpi.com/2076-3417/15/11/5968
work_keys_str_mv AT ryosukesogame dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT yukitominaga dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT momokaechigoya dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT kiyotakanakagawa dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT michihirofukushima dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT teruomiyazawa dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT mikiokinoshita dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen
AT shinjiyamashita dietaryethanolamineplasmalogenfromascidianalleviateschronichepaticinjuryinmicetreatedwithcontinuousacetaminophen